Life Sciences: Transactional
UK Guide 2025 : UK-wide
Band 1
Contact number
(020) 7583 4055Chambers Review
Cooley advises on weighty IP-driven corporate and financing transactions. The firm is also a leading destination for complex licensing, joint venture and collaboration agreements. The team is experienced advising European companies listing on Nasdaq as a foreign private issuer or with a dual listing.
Work Highlights
- Cooley advised Bavarian Nordic in a definitive agreement to acquire Emergent BioSolutions’ travel vaccines portfolio for up to $380 million, including an upfront payment of $270 million.
Strengths
Provided by Chambers
"The Cooley team is broad and provides a high service level. The lawyers are very knowledgeable, experienced and pragmatic."
"Cooley have specialist experts with long experience who have seen many different deals."
"The depth of experience and speciality at Cooley in the life sciences space makes the team very credible and able to engage in complex matters."
"The Cooley team is broad and provides a high service level. The lawyers are very knowledgeable, experienced and pragmatic."
"Cooley have specialist experts with long experience who have seen many different deals."
"The depth of experience and speciality at Cooley in the life sciences space makes the team very credible and able to engage in complex matters."
Notable Practitioners
John Wilkinson is a go-to for capital financing for emerging biotechnology companies and acquisitions advice for large corporate clients. He is also recommended for his advice on ambitious collaboration agreements.
"John is a very experienced, knowledgeable lawyer with not only the expertise but a very pleasant manner when assisting in complex negotiations."
"One of the best. John is a long trusted lawyer with wide experience and commercial smarts."
"John is very talented, knowledgeable and pragmatic. He has a strong business understanding and an excellent science background."
Nicola Maguire handles a range of investments, financing rounds, sales and acquisitions for biotech start-ups and pharmaceutical corporations. She often acts on matters with cross-border and international implications.
"Nicola is a talented lawyer with a pragmatic approach."
"Nicola is a responsive and flexible partner."